Improved prognosis of intracranial germ cell-tumors (GCTs): Results of the makei 89 study
✍ Scribed by Calaminus, G; Teske, C; Göbel, U
- Book ID
- 122537524
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 164 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In January 1983, the German Society of Pediatric Oncology started a cooperative trial (MAKEI 83) for non-testicular germ-cell tumors. The pilot phase closed in December 1985. The treatment regimen was stratified according to histology, tumor site and tumor stage. In malignant non-seminomatous germ-c
## Abstract A trial was undertaken to assess the efficacy and toxicity of high‐dose cisplatin and etoposide in children with newly diagnosed advanced malignant germ cell tumors. A total of eleven children and adolescents were treated with courses of high dose cisplatin 30 mg/m^2^/day and etoposide
## Abstract ## Background and Aims About 20% of patients with germ cell tumor (GCT) are still resistant to therapy. To investigate which features are present in resistant patients, a multicenter study on GCT in children was undertaken to correlate clinical and laboratory parameters with the outcom